NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Cash and Bank History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹1,551 Cr | ₹2,176 Cr | ₹953 Cr | ₹546 Cr | ₹206 Cr |
What is the latest Cash and Bank ratio of NATCO PHARMA ?
| Year | Cash and Bank |
|---|---|
| Mar2026 | ₹1,551 Cr |
| Mar2025 | ₹2,176 Cr |
| Mar2024 | ₹953 Cr |
| Mar2023 | ₹546 Cr |
| Mar2022 | ₹206 Cr |
How is Cash and Bank of NATCO PHARMA Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,551 Cr | -28.73 | |
| Mar2025 | ₹2,176 Cr | 128.36 | |
| Mar2024 | ₹953 Cr | 74.43 | |
| Mar2023 | ₹546 Cr | 165.07 | |
| Mar2022 | ₹206 Cr | - | |
Compare Cash and Bank of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,397.8 Cr | -0.7% | -3.4% | -3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -0.7% |
-3.4% |
-3% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses